A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study

AIMS: To compare the safety and efficacy of insulin glargine 300 U/mL (Gla‐300) versus first‐generation standard‐of‐care basal insulin analogues (SOC‐BI; insulin glargine 100 U/mL or insulin detemir) at 6 months. METHODS: In the 12‐month, open‐label, multicentre, randomized, pragmatic ACHIEVE Contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Meneghini, Luigi F., Sullivan, Sean D., Oster, Gerry, Busch, Robert, Cali, Anna M. G., Dauchy, Arnaud, Gill, Jasvinder, Bailey, Timothy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692902/
https://www.ncbi.nlm.nih.gov/pubmed/32729217
http://dx.doi.org/10.1111/dom.14152

Ejemplares similares

Ejemplares similares